Related Experiment Video
Updated: Sep 19, 2025

Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis
Published on: July 11, 2014
Reduced and rearranged metabolite structures after metandienone administration: New promising metabolites for
Jakob Steff1, Francesco Molaioni2, Nils Schlörer3
1Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, Berlin 14195, Germany.
Abstract:
Metandienone (MD) is a representative of the group of anabolic androgenic steroids and is commonly used in professional and amateur sports despite being a banned substance by the World Anti-Doping Agency (WADA). Metabolites of MD show high structural similarity to related anabolic androgenic steroids (AAS) such as dehydrochloromethyltestosterone (DHCMT). This led to the hypothesis that metabolites of MD with structures similar to long-term metabolites of DHCMT may be detectable. Therefore, a human administration study of MD was carried out and analyzed with the focus on metabolite structures with partly or fully reduced A-rings and eventually with rearranged D-rings with 17ξ-hydroxymethyl-17ξ-methyl substructures. Synthesized diastereomeric reference material allowed the establishment of a confident identification and characterization of excreted targeted compounds by gas chromatography-mass spectrometry. In this way, the excretion of inter alia 17α-methyl-5β-androstane-3α,17β-diol (T3), 17β-methyl-5β-androstane-3α,17α-diol (T7), 17α-hydroxymethyl-17β-methyl-18-nor-5β-androst-13-en-3α-ol (N3), 17α-hydroxymethyl-17β-methyl-18-nor-5β-androsta-1,13-dien-3α-ol (E3) and 17,17-dimethyl-18-nor-5β-androst-13-en-3α-ol (3α5βnorTHMT) was confirmed. Excretion curves of previously known and newly discovered metabolites enabled the assessment of the relationship between the chemical structure and the time of excretion. In addition to further assembling the picture of human metabolism of AAS with newly discovered metabolites, the detection of E3 allows the presumption to be a promising future candidate for a new long-term marker in anti-doping analyses with indications for an increased detection window.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Related Concept Videos
Phase I Reactions: Reductive Reactions
Drug Metabolism: Phase II Reactions
Drug Biotransformation: Overview
Drug Metabolism: Phase I Reactions
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...